Write to the Correspondence Desk

Editorial correspondence

Gurl Peptide is glad to hear about the research record: a citation quoted loosely, a regulatory reference that has aged out, or a peer-reviewed study on PT-141, Kisspeptin or Melanotan II that ought to join the references page. Notes that sharpen accuracy are the ones worth the most here.

The easiest messages to act on name three things: the page in question, the exact line at issue, and a source to back the change — a DOI or PubMed ID where you have one. With those, a proposed correction can be checked against the record fast.

Editorial mailbox: editors@gurlpeptide.com

What this desk cannot do

So the boundaries are plain. Gurl Peptide reads and cites the literature and nothing more — no clinic, no shop, no counseling service. It will not:

• Weigh in on, endorse, or advise anyone's personal use of the peptides covered here.
• Put a number, timetable, or route to any individual's use.
• Read personal symptoms, situations, or clinical choices.
• Sell, source, rank, or help track down any compound from any supplier.
• Field questions from athletes under anti-doping rules, several of these compounds sitting inside WADA's non-approved-substances category.

Anyone after clinical guidance should see a licensed provider in their own jurisdiction. Replies here are not promised and can lag; the mailbox is checked only now and then.